Annual SGA
$26.35 M
+$6.00 M+29.49%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual SGA is $26.35 million, with the most recent change of +$6.00 million (+29.49%) on December 31, 2023.
- During the last 3 years, TCRX annual SGA has risen by +$19.61 million (+290.95%).
- TCRX annual SGA is now at all-time high.
Performance
TCRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$7.41 M
-$364.00 K-4.68%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly SGA is $7.41 million, with the most recent change of -$364.00 thousand (-4.68%) on September 30, 2024.
- Over the past year, TCRX quarterly SGA has increased by +$1.51 million (+25.70%).
- TCRX quarterly SGA is now -4.68% below its all-time high of $7.77 million, reached on June 30, 2024.
Performance
TCRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.17 B
-$111.30 M-10.47%
September 30, 2024
Summary
- As of February 7, 2025, TCRX TTM SGA is -$1.17 billion, with the most recent change of -$111.30 million (-10.47%) on September 30, 2024.
- Over the past year, TCRX TTM SGA has dropped by -$1.20 billion (-4558.54%).
- TCRX TTM SGA is now -2596.86% below its all-time high of -$43.53 million.
Performance
TCRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TCRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.5% | +25.7% | -4558.5% |
| 3 y3 years | +290.9% | +25.7% | -4558.5% |
| 5 y5 years | +452.7% | +25.7% | -4558.5% |
TCRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +90.6% | -4.7% | +66.6% | -313.9% | at low |
| 5 y | 5-year | at high | +452.7% | -4.7% | +565.1% | -2596.9% | at low |
| alltime | all time | at high | +452.7% | -4.7% | +565.1% | -2596.9% | at low |
TScan Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $7.41 M(-4.7%) | $28.43 M(+5.6%) |
| Jun 2024 | - | $7.77 M(+9.8%) | $26.91 M(+4.8%) |
| Mar 2024 | - | $7.08 M(+14.9%) | $25.67 M(-2.6%) |
| Dec 2023 | $26.35 M(+29.5%) | $6.16 M(+4.5%) | $26.35 M(+0.1%) |
| Sep 2023 | - | $5.89 M(-9.8%) | $26.33 M(+3.9%) |
| Jun 2023 | - | $6.53 M(-15.9%) | $25.35 M(+7.3%) |
| Mar 2023 | - | $7.77 M(+26.5%) | $23.63 M(+16.1%) |
| Dec 2022 | $20.35 M | $6.14 M(+25.1%) | $20.35 M(+9.1%) |
| Sep 2022 | - | $4.91 M(+2.1%) | $18.66 M(+4.8%) |
| Jun 2022 | - | $4.81 M(+7.0%) | $17.80 M(+13.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $4.49 M(+1.0%) | $15.72 M(+13.7%) |
| Dec 2021 | $13.83 M(+105.1%) | $4.45 M(+9.9%) | $13.83 M(+15.0%) |
| Sep 2021 | - | $4.05 M(+48.5%) | $12.02 M(+24.9%) |
| Jun 2021 | - | $2.73 M(+4.6%) | $9.62 M(+20.1%) |
| Mar 2021 | - | $2.61 M(-1.3%) | $8.01 M(+18.8%) |
| Dec 2020 | $6.74 M(+41.4%) | - | - |
| Dec 2020 | - | $2.64 M(+60.3%) | $6.74 M(+64.4%) |
| Sep 2020 | - | $1.65 M(+47.9%) | $4.10 M(+67.2%) |
| Jun 2020 | - | $1.11 M(-16.7%) | $2.45 M(+83.3%) |
| Mar 2020 | - | $1.34 M | $1.34 M |
| Dec 2019 | $4.77 M | - | - |
FAQ
- What is TScan Therapeutics annual SGA?
- What is the all time high annual SGA for TScan Therapeutics?
- What is TScan Therapeutics annual SGA year-on-year change?
- What is TScan Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for TScan Therapeutics?
- What is TScan Therapeutics quarterly SGA year-on-year change?
- What is TScan Therapeutics TTM SGA?
- What is the all time high TTM SGA for TScan Therapeutics?
- What is TScan Therapeutics TTM SGA year-on-year change?
What is TScan Therapeutics annual SGA?
The current annual SGA of TCRX is $26.35 M
What is the all time high annual SGA for TScan Therapeutics?
TScan Therapeutics all-time high annual SGA is $26.35 M
What is TScan Therapeutics annual SGA year-on-year change?
Over the past year, TCRX annual SGA has changed by +$6.00 M (+29.49%)
What is TScan Therapeutics quarterly SGA?
The current quarterly SGA of TCRX is $7.41 M
What is the all time high quarterly SGA for TScan Therapeutics?
TScan Therapeutics all-time high quarterly SGA is $7.77 M
What is TScan Therapeutics quarterly SGA year-on-year change?
Over the past year, TCRX quarterly SGA has changed by +$1.51 M (+25.70%)
What is TScan Therapeutics TTM SGA?
The current TTM SGA of TCRX is -$1.17 B
What is the all time high TTM SGA for TScan Therapeutics?
TScan Therapeutics all-time high TTM SGA is -$43.53 M
What is TScan Therapeutics TTM SGA year-on-year change?
Over the past year, TCRX TTM SGA has changed by -$1.20 B (-4558.54%)